(Q44014583)

28 November 2017

Systemic lupus erythematosus in a child receiving long-term interferon therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1538292

systemic lupus erythematosus

6 October 2022

main subject

1 reference

A. Tolaymat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1538292

6 October 2022

B. Leventhal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1538292

6 October 2022

A. Sakarcan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1538292

6 October 2022

H. Kashima

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1538292

6 October 2022

C. Monteiro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1538292

6 October 2022

language of work or name

English

0 references

publication date

1 March 1992

1 reference

The Journal of Pediatrics

28 November 2017

1 reference

28 November 2017

120

1 reference

28 November 2017

429-432

1 reference

28 November 2017

3

1 reference

Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis.

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980913-8

Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980913-8

Human interferon as a therapeutic agent: a decade passes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980913-8

Acute renal failure during therapy with recombinant human gamma interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980913-8

Treatment of recurrent laryngeal papillomatosis with anartificial interferon inducer (poly ICLC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980913-8

The effect of gamma-interferon on MHC antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980913-8

Recombinant alfa-2b-interferon therapy in untreated, stages A and B chronic lymphocytic leukemia. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980913-8

Immune thrombocytopenia following alpha-interferon therapy in patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980913-8

Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980913-8

Lethality of interferon preparations for newborn mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980913-8

Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980913-8

Effects of interferon-alpha on the expression of a lupus idiotype in normal humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980913-8

Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980913-8

10.1016/S0022-3476(05)80913-8

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference